Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: Differential implications for prevention of transfusional transmission

Cossart, 1975, Parvovirus-like particles in human sera, Lancet, 1, 72, 10.1016/S0140-6736(75)91074-0 Pattison, 1981, Parvovirus infections and hypoplastic crisis in sickle-cell anaemia, Lancet, ?, 664, 10.1016/S0140-6736(81)91579-8 Serjeant, 1992, Sero-epidemiology of human parvovirus infection in homozygous sickle cell disease (abstract), Blood, 50, 10A Young, 1988, Hematologic and hematopoietic consequences of B19 parvovirus infection, Semin Hematol, 25, 159 Jones, 1990, Human parvovirus infection in children and severe anaemia seen in an area endemic for malaria, J Trop Med Hyg, 93, 67 Mortimer, 1983, A human parvovirus-like virus inhibits haematopoietic colony formation in vitro, Nature, 302, 426, 10.1038/302426a0 Young, 1996, Parvovirus infection and its treatment, Clin Exp Immunol, 104, 26, 10.1111/cei.1996.104.s1.26 Lefrère, 1996, Le parvovirus B19, 169 Hall, 1990, Prospective study of human parvovirus (B19) infection in pregnancy, Br Med J, 300, 1166, 10.1136/bmj.300.6733.1166 Anderson, 1983, Human parvovirus, the cause of erythema infectiosum (fifth disease)?, Lancet, 1, 1378, 10.1016/S0140-6736(83)92152-9 Woolf, 1989, Clinical manifestation of human parvovirus B19 in adults, Arch Intern Med, 149, 1153, 10.1001/archinte.1989.00390050111022 White, 1985, Human parvovirus arthropathy, Lancet, 1, 419, 10.1016/S0140-6736(85)91145-6 Serjeant, 1993, Human parvovirus infection in homozygous sickle cell disease, Lancet, 341, 1237, 10.1016/0140-6736(93)91145-C Erdman, 1991, Human parvovirus B19 specific IgG, IgA and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum, J Med Virol, 35, 110, 10.1002/jmv.1890350207 Young, 1996, Parvoviruses, 2199 Frickhofen, 1990, Persistent parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS, Ann Intern Med, 113, 926, 10.7326/0003-4819-113-12-926 Naides, 1993, Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy, J Infect Dis, 168, 101, 10.1093/infdis/168.1.101 Nigro, 1992, Parvovirus-B19-related pancytopenia in children with HIV infection, Lancet, 340, 115, 10.1016/0140-6736(92)90436-7 Fuller, 1996, Parvovirus B19 in HIV infection: A treatable cause of anemia, Pathology, 28, 277, 10.1080/00313029600169154 Ramratnam, 1995, Management of persistent B19 parvovirus infection in AIDS, Br Med J, 91, 90 van Elsacker-Niele, 1996, Prevalence of parvovirus B 19 infection in patients infected with Human Immunodeficiency Virus, Clin Infect Dis, 23, 1255, 10.1093/clinids/23.6.1255 Kurtzman, 1989, Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy, N Engl J Med, 321, 519, 10.1056/NEJM198908243210807 Kurtzman, 1988, Persistent B19 parvovirus infection as a cause of severe chronic anemia in children with acute lymphocytic leukaemia, Lancet, 2, 1159, 10.1016/S0140-6736(88)90233-4 Harris, 1992, Parvovirus B19 for the hematologist, Am J Hematol, 39, 119, 10.1002/ajh.2830390209 Anderson, 1985, Experimental parvoviral infection in humans, J Infect Dis, 152, 257, 10.1093/infdis/152.2.257 Mc Omish, 1993, Detection of parvovirus B19 in donated blood: a model system for screening by Polymerase Chain Reaction, J Clin Microbiol, 31, 323, 10.1128/JCM.31.2.323-328.1993 Torok, 1992, Prenatal diagnosis of intra-uterine infection with parvovirus B19 by the polymerase chain reaction technique, Clin Infect Dis, 14, 149, 10.1093/clinids/14.1.149 Zakrzewska, 1992, Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by nested polymerase chain reaction, Br Med J, 81, 407 Yoto, 1995, Incidence of human parvovirus B19 DNA detection in blood donors, Br Med J, 91, 1017 Yaegashi, 1989, Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propaged in vitro, J Virol Meth, 26, 171, 10.1016/0166-0934(89)90146-8 Schwarz, 1989, Seroprevalence of human parvovirus B19 infection in Sao Tome and Principe, Malawi and Mascarene Island, Zbl Bakt, 271, 231, 10.1016/S0934-8840(89)80077-5 Cohen, 1983, Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV), J Hyg Camb, 91, 113, 10.1017/S0022172400060095 Musiani, 1995, Parvovirus B19 clearance from peripheral blood after acute infection, J Infect Dis, 172, 1360, 10.1093/infdis/172.5.1360 Bruu, 1995, Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19, J Clin Microbiol, 33, 1363, 10.1128/JCM.33.5.1363-1365.1995 Cohen, 1988, The seroprevalence of antibody to human parvovirus B19 in England and Wales, J Med Microbiol, 25, 151, 10.1099/00222615-25-2-151 Schwarz, 1987, Human parvovirus B19 infections in the UK 1984–1986, Lancet, 1, 738 Anderson, 1986, Detection of antibodies and antigens of human parvovirus B19 by Enzyme-Linked ImmunoSorbent Assay, J Clin Microbiol, 24, 522, 10.1128/JCM.24.4.522-526.1986 Cohen, 1995, Parvovirus B19: an expanding spectrum of disease, Br Med J, 311, 1549, 10.1136/bmj.311.7019.1549 Frickhofen, 1990, Persistent B19 parvovirus infection: a treatable cause of anemia in AIDS, Ann Intern Med, 113, 926, 10.7326/0003-4819-113-12-926 Kurtzman, 1989, Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy, N Engl J Med, 321, 519, 10.1056/NEJM198908243210807 van Aken, 1995, Risk analysis to assess potential value of Gene Amplification Testing for improving plasma product safety, 8